NCT03430011 2024-05-24EVOLVEJuno Therapeutics, a Subsidiary of CelgenePhase 1/2 Completed165 enrolled 38 charts
NCT02326376 2020-01-18Kineret CAPS Post Authorisation StudySwedish Orphan BiovitrumCompleted12 enrolled